Project Details
| Short title | CA0581019 |
|---|---|
| Acronym | ALUMMINATE RRMM |
| Status | Active |
| Effective start/end date | 15/02/24 → 17/01/29 |
CTU: A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM)
- Menzies Wojtowicz, Monique (Primary Chief Investigator)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
- TAIDI, Gina (Clinical Trial Unit Staff)
- Martin, Lewis (Clinical Trial Unit Staff)
Project: Research